NEW YORK (GenomeWeb News) – Pressure BioSciences today announced the closing of the third and final tranche of its Series J Private Placement of Convertible Preferred Stock and Warrants that raised a total $2 million.

The first and second tranches closed in February and March. Investors in the Series J round included all members of Pressure Bio's board, as well as new and existing accredited investors in the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.